Search

Thyroid ultrasound elastography: does nodule stiffness predict malignancy?

Approximately 50% of the general population has a thyroid nodule while 5-15% of these are malignant [1]. A major challenge, therefore, is how to detect the malignant nodules for appropriate, timely treatment and avoid unnecessary, costly investigations for the remainder....

Promoting human rights of deaf communities in low-resource settings

Stigma and misconceptions about deafness are serious impediments for many deaf people to realise rights and potential in some of the most challenging situations globally. Around 430 million people are estimated to live with moderate or higher levels of hearing...

Endotypes in chronic rhinosinusitis: clinical relevance

Identifying endotypes enables personalised therapies that target specific pathophysiological processes, potentially resulting in better treatment outcomes for patients. The contemporary model of chronic rhinosinusitis (CRS) pathogenesis revolving around endotype, in combination with an expanding toolbox of diagnostics and therapeutics, enables...

Lyric 24/7 hearing: could it help those with tinnitus?

About Lyric Hearing Since its launch in 2008, Lyric represents the first and only device of its kind establishing a new category of hearing solution: 24/7 extended wear. Lyric is placed several millimetres within the ear canal, near the tympanic...

Screening: evaluating the outcomes of early intervention

Newborn hearing screening is now the accepted standard of care in several countries, and is becoming increasingly more established worldwide. White [1] reported eight countries screening over 90% of newborns, ten screening between 25-89% of births and a further 54...

The basis of the bargain: outcomes not inputs

There are international drivers focusing our attention on measuring outcomes; Anthony Hogan looks at the data to see how we are currently measuring up. Introduction A global paradigm change is impacting on the provision of disability services. At its heart,...

Hearing care systems in Europe – can we do more?

52 million Europeans experience hearing loss but many don’t find their way to professional hearing care. Lidia Best looks at strategies to improve the uptake of amplification at a national level [1]. With rising numbers of people experiencing hearing loss,...

mHealth technologies empower users of hearing healthcare

The opportunities provided by mhealth technologies to personalise and encourage user involvement in hearing healthcare has many benefits for adults with hearing loss. Melanie Ferguson explains how mhealth can empower hearing aid users. Connected health is likely to transform hearing...

Promoting human rights of deaf communities in low-resource settings

Stigma and misconceptions about deafness are serious impediments for many deaf people to realise rights and potential in some of the most challenging situations globally. Around 430 million people are estimated to live with moderate or higher levels of hearing...

Tinnitus treatment device from concept to commercialisation

Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...

Big data and the future of cochlear implant aftercare

With a million people using cochlear implants worldwide, the time is right for us to harness this vast data for patient benefit. Every day, cochlear implant (CI) processors quietly collect data: how long they’re worn, how often users switch programs...